Overview

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

Status:
Completed

Trial end date:
2015-11-01

Target enrollment:

Participant gender:

Summary

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Voriconazole